Inhibition of tumor growth by elimination of granulocytes.
Open Access
- 1 January 1995
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 181 (1) , 435-440
- https://doi.org/10.1084/jem.181.1.435
Abstract
As observed for many types of cancers, heritable variants of ultraviolet light-induced tumors often grow more aggressively than the parental tumors. The aggressive growth of some variants is due to the loss of a T cell-recognized tumor-specific antigen; however, other variants retain such antigens. We have analyzed an antigen retention variant and found that the variant tumor cells grow at the same rate as the parental tumor cells in vitro, but grew more rapidly than the parental cells in the T cell-deficient host. The growth of the variant cells was stimulated in vitro by factors released from tumor-induced leukocytes and by several defined growth factors. In addition, the variant cancer cells actually attracted more leukocytes in vitro than the parental cells. Furthermore, elimination of granulocytes in vivo in nude mice by a specific antigranulocyte antibody inhibited the growth of the variant cancer, indicating that this tumor requires granulocytes for rapid growth.Keywords
This publication has 33 references indexed in Scilit:
- Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factorPublished by Elsevier ,2004
- Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune responseImmunology Today, 1992
- An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4Science, 1992
- Cytokines in context.The Journal of cell biology, 1991
- CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity.Journal of Clinical Investigation, 1990
- Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow.Journal of Clinical Investigation, 1989
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989
- A significant part of macrophage-derived growth factor consists of at least two forms of PDGFCell, 1985
- Resistance of human tumor cells in vitro to oxidative cytolysis.Journal of Clinical Investigation, 1985
- Molecular cloning of gene sequences regulated by platelet-derived growth factorCell, 1983